IL17A and systemic lupus erythematosus: Doreau et al. (2009) showed that IL-17 alone or in combination with B cell-activating factor controlled the survival and proliferation of B cells and their differentiation into immunoglobulin-secreting cells supporting development of SLE symptoms.